USPTO 2015–2025 USPTO PatentsView US Corporation

Singular Genomics Systems, Inc.

USPTO PatentsView assignee record - 115 granted patents across 26 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

115

Total patents granted

CPC technology areas

19.6

Avg claims per patent

5-year filing velocity

The verdict

Singular holds 115 US patents across 26 technology areas, rank #3,267 of 50,000 tracked assignees.

#3,267
of 50,000 US assignees by volume: Top 1%
by Innovation Score (66.2/100): 19.6
avg claims per patent

Portfolio overview

Singular Genomics Systems, Inc. has been granted 115 US utility patents between 2020 and 2025, placing Singular Genomics Systems, Inc. at rank #3,267 across all assignees tracked by PlainPatent. This portfolio spans 26 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.6 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Singular Genomics Systems, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Singular sits between Omron Automotive Electronics Co., Ltd. (115 patents, rank #3,263) and Asana, Inc. (114 patents, rank #3,271) - the closest US assignees by grant volume. The composite Innovation Score of 66.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 115 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Singular Genomics Systems, Inc.'s 19.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 26 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Singular Genomics Systems, Inc. against peers pursuing similar technology classes.

Omron Automotive

115
Pi-design

115
Shofu

115
Simpson Strong-tie

115
Tmeic

115
UTI

115
Singular Genomics… ◀

115
Abbyy Development

114
Asana

114

What this shows Singular holds 115 patents at rank #3,267, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Singular

By rank, the assignees closest to #3,267 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Singular's primary technology class.

Singular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Singular Genomics Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	1.7%
2021	5	4.3%
2022	15	13.0%
2023	25	21.7%
2024	41	35.7%
2025	27	23.5%

Which technologies does Singular Genomics Systems, Inc. patent most?

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 75

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 29

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 19

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 18

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 16

C12Y - ENZYMES 12

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 9

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 8

C09B - ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES ; , e.g. PIGMENTS; MORDANTS; LAKES 6

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 4

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 4

C09K - MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE 3

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 3

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 3

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3

Top 15 of 26 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Where it ranks

Overall rank by patents

#3,267

Across all tracked assignees

Innovation Score

66.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Singular Genomics Systems, Inc. hold?

Singular Genomics Systems, Inc. holds 115 US granted patents filed between 2020 and 2025, spanning 26 technology areas.

What is Singular Genomics Systems, Inc.'s Innovation Score?

Singular Genomics Systems, Inc. has an Innovation Score of 66.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Singular Genomics Systems, Inc. focus on?

Singular Genomics Systems, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 75 patents. The company has filed patents in 26 CPC subclasses total.

Is Singular Genomics Systems, Inc.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Singular Genomics Systems, Inc..

What does claim depth mean for Singular Genomics Systems, Inc.'s patents?

Singular Genomics Systems, Inc.'s patents average 19.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Singular Genomics Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Singular's 115 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Singular ranks #3,267 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12Q - see who else leads that technology area. C12Q leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.